Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study.
Victoria RosbergMikkel JessenCamilla QvortrupHenry George SmithPeter-Martin KrarupPublished in: Acta oncologica (Stockholm, Sweden) (2023)
5-year overall survival was significantly higher in patients with high-risk stage II colon cancer treated with adjuvant chemotherapy compared with no chemotherapy. Adjuvant treatment was given to less than half of the patients who were eligible for it.